Prchal JT - Search Results

1

Limited efficacy of BMS-911543 in a murine model of Janus kinase 2 V617F myeloproliferative neoplasm.

Pomicter AD, Eiring AM, Senina AV, Zabriskie MS, Marvin JE, Prchal JT, O'Hare T, Deininger MW. Pomicter AD, et al. Among authors: prchal jt. Exp Hematol. 2015 Jul;43(7):537-45.e1-11. doi: 10.1016/j.exphem.2015.03.006. Epub 2015 Apr 24. Exp Hematol. 2015. PMID: 25912019 Free PMC article.

2

Polycythemia vera is not initiated by JAK2V617F mutation.

Nussenzveig RH, Swierczek SI, Jelinek J, Gaikwad A, Liu E, Verstovsek S, Prchal JF, Prchal JT. Nussenzveig RH, et al. Among authors: prchal jf, prchal jt. Exp Hematol. 2007 Jan;35(1):32-8. doi: 10.1016/j.exphem.2006.11.012. Exp Hematol. 2007. PMID: 17198871 Free article.

3

In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele.

Gaikwad A, Nussenzveig R, Liu E, Gottshalk S, Chang K, Prchal JT. Gaikwad A, et al. Among authors: prchal jt. Exp Hematol. 2007 Apr;35(4):587-95. doi: 10.1016/j.exphem.2006.12.007. Exp Hematol. 2007. PMID: 17379069 Free PMC article.

4

Imatinib effect on growth and signal transduction in polycythemia vera.

Gaikwad A, Verstovsek S, Yoon D, Chang KT, Manshouri T, Nussenzveig R, Cortes J, Vainchenker W, Prchal JT. Gaikwad A, et al. Among authors: prchal jt. Exp Hematol. 2007 Jun;35(6):931-8. doi: 10.1016/j.exphem.2007.03.012. Exp Hematol. 2007. PMID: 17533047

5

Study of two tyrosine kinase inhibitors on growth and signal transduction in polycythemia vera.

Gaikwad A, Prchal JT. Gaikwad A, et al. Among authors: prchal jt. Exp Hematol. 2007 Nov;35(11):1647-56. doi: 10.1016/j.exphem.2007.08.018. Exp Hematol. 2007. PMID: 17976517 Free PMC article.

6

Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis.

Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT. Bruchova H, et al. Among authors: prchal jt. Exp Hematol. 2007 Nov;35(11):1657-67. doi: 10.1016/j.exphem.2007.08.021. Exp Hematol. 2007. PMID: 17976518 Free PMC article.

7

Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001.

Nussenzveig RH, Cortes J, Sever M, Quintás-Cardama A, Ault P, Manshouri T, Bueso-Ramos C, Prchal JT, Kantarjian H, Verstovsek S. Nussenzveig RH, et al. Among authors: prchal jt. Int J Hematol. 2009 Jul;90(1):58-63. doi: 10.1007/s12185-009-0345-y. Epub 2009 May 30. Int J Hematol. 2009. PMID: 19484334 Free PMC article. Clinical Trial.

8

Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms.

Wang X, LeBlanc A, Gruenstein S, Xu M, Mascarenhas J, Panzera B, Wisch N, Parker C, Goldberg JD, Prchal J, Hoffman R, Najfeld V. Wang X, et al. Exp Hematol. 2009 Oct;37(10):1194-200. doi: 10.1016/j.exphem.2009.07.003. Epub 2009 Jul 15. Exp Hematol. 2009. PMID: 19615425 Free article.

9

JAK2 kinase inhibitors and myeloproliferative disorders.

Chen AT, Prchal JT. Chen AT, et al. Among authors: prchal jt. Curr Opin Hematol. 2010 Mar;17(2):110-6. doi: 10.1097/MOH.0b013e3283366b91. Curr Opin Hematol. 2010. PMID: 20087176 Review.

10

In vitro and in vivo characterization of SGI-1252, a small molecule inhibitor of JAK2.

Ahmed KB, Warner SL, Chen A, Gourley ES, Liu X, Vankayalapati H, Nussenzveig R, Prchal JT, Bearss DJ, Parker CJ. Ahmed KB, et al. Among authors: prchal jt. Exp Hematol. 2011 Jan;39(1):14-25. doi: 10.1016/j.exphem.2010.09.013. Epub 2010 Oct 8. Exp Hematol. 2011. PMID: 20934482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters